KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...

Enhanced Genomics ('Enhanced' or 'the Company'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for co ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced a new community-developed method, CiFi, ...

For decades, the process of drug discovery has been a prolonged, costly, and unpredictable endeavor — an effort that ...

SKY92 and next-generation sequencing (NGS) of bone marrow tumour cells into routine patient care for the first time in Ireland ...

Explore the groundbreaking AI genomics platform, Inference, launched by Variant Bio to enhance drug discovery using genetic ...

Incregen Therapeutics Advances First-in-Class GIP Ligand Antagonist INC-118 into IND-Enabling Development to Address Long-Term Obesity Management INC-118 directly antagonizes the circulating Glucose ...

Grace E. Colón, Ph.D., Appointed Chair of the Board of DirectorsJohn Glasspool Appointed Board DirectorLekhan Shivashankar Appointed Chief of ...

And just like that, 2025 has come to a close. They say one man's misfortune is another man's opportunity, but collectively, ...

Beam Therapeutics Inc. (NASDAQ: BEAM) is among the 12 Best Genomics Stocks to Invest In.

Abu Dhabi marks a landmark achievement in becoming the first in the world to deliver ITVISMA (onasemnogene abeparvovec) for ...

Researchers have identified a new class of RNA molecule, called smOOPs, which support cellular phase separation, where macromolecules form biomolecular condensates that are critical for cell function.